13F HOLDINGS REPORT
FCPM III SERVICES B.V.
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0000950123-24-011523
Total Value
$582.3M
Positions
11
Other Managers
2
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DYNE THERAPEUTICS INC | DYN | 4,525,498 | $162.6M | 27.92% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 6,635,391 | $110.1M | 18.92% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 5,196,070 | $86.3M | 14.81% |
| 4 | REPLIMUNE GROUP INC | REPL | 4,866,449 | $53.3M | 9.16% |
| 5 | BICYCLE THERAPEUTICS PLC | BCYC | 2,339,961 | $53.0M | 9.09% |
| 6 | DYNE THERAPEUTICS INC | DYN | 1,428,571 | $51.3M | 8.81% |
| 7 | ENGENE HOLDINGS INC | ENGNW | 5,783,752 | $38.2M | 6.56% |
| 8 | ENGENE HOLDINGS INC | ENGNW | 2,894,199 | $19.1M | 3.28% |
| 9 | ENGENE HOLDINGS INC | ENGNW | 2,403,072 | $5.0M | 0.87% |
| 10 | ACHILLES THERAPEUTICS PLC | 00449L102 | 2,390,050 | $2.4M | 0.42% |
| 11 | ENGENE HOLDINGS INC | ENGNW | 475,076 | $997,660 | 0.17% |